Hennion & Walsh Asset Management, Inc. Sage Therapeutics, Inc. Transaction History

Hennion & Walsh Asset Management, Inc.

$2.15 Billion
Q1 2025

A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 14,828 shares of SAGE stock, worth $122,775. This represents 0.01% of its overall portfolio holdings.

Number of Shares

14,828

Previous 18,246 18.73%

Holding current value

$122,775

Previous $99,000 23.23%

% of portfolio

0.01%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 10, 2025	SELL	$5.55 - $8.66 $18,969 - $29,599	-3,418 Reduced 18.73%	14,828 $122,000
Q4 2024 Jan 14, 2025	SELL	$4.78 - $8.57 $101,202 - $181,444	-21,172 Reduced 53.71%	18,246 $99,000
Q3 2024 Oct 22, 2024	SELL	$7.02 - $13.08 $16,981 - $31,640	-2,419 Reduced 5.78%	39,418 $284,000
Q2 2024 Jul 19, 2024	SELL	$10.58 - $17.9 $261,643 - $442,666	-24,730 Reduced 37.15%	41,837 $454,000
Q1 2024 Apr 17, 2024	BUY	$18.62 - $26.95 $94,366 - $136,582	5,068 Added 8.24%	66,567 $1.25 Million
Q4 2023 Jan 10, 2024	SELL	$17.1 - $22.26 $410,331 - $534,150	-23,996 Reduced 28.07%	61,499 $1.33 Million
Q3 2023 Oct 27, 2023	BUY	$16.75 - $48.98 $71,388 - $208,752	4,262 Added 5.25%	85,495 $1.76 Million
Q2 2023 Aug 09, 2023	BUY	$40.65 - $59.54 $344,549 - $504,661	8,476 Added 11.65%	81,233 $3.82 Million
Q1 2023 Apr 20, 2023	BUY	$37.27 - $46.57 $64,849 - $81,031	1,740 Added 2.45%	72,757 $3.05 Million
Q4 2022 Jan 12, 2023	SELL	$32.2 - $43.61 $301,810 - $408,756	-9,373 Reduced 11.66%	71,017 $2.71 Million
Q3 2022 Nov 14, 2022	BUY	$32.28 - $43.27 $63,656 - $85,328	1,972 Added 2.51%	80,390 $3.15 Million
Q2 2022 Jul 19, 2022	BUY	$27.52 - $37.99 $436,632 - $602,749	15,866 Added 25.36%	78,418 $2.53 Million
Q1 2022 Apr 26, 2022	BUY	$30.71 - $45.71 $315,207 - $469,167	10,264 Added 19.63%	62,552 $2.07 Million
Q4 2021 Feb 14, 2022	BUY	$37.06 - $47.11 $533,404 - $678,054	14,393 Added 37.98%	52,288 $2.22 Million
Q3 2021 Nov 12, 2021	SELL	$40.26 - $57.37 $33,617 - $47,903	-835 Reduced 2.16%	37,895 $1.68 Million
Q2 2021 Aug 13, 2021	SELL	$54.88 - $79.29 $23,104 - $33,381	-421 Reduced 1.08%	38,730 $2.2 Million
Q1 2021 May 17, 2021	BUY	$70.65 - $96.76 $2.77 Million - $3.79 Million	39,151 New	39,151 $2.93 Million

Others Institutions Holding SAGE

# of Institutions

195

Shares Held

45M

Call Options Held

304K

Put Options Held

117K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $492M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hennion & Walsh Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hennion & Walsh Asset Management, Inc. with notifications on news.

Account

Hennion & Walsh Asset Management, Inc. Sage Therapeutics, Inc. Transaction History